News and events

News and events

הזמנה ליום עיון 2

Invitation- Isotopia organizing a workshop for nuclear medicine and neurologists on FDOPA imaging of PD

Dear Doctors we are happy to invite you to a lecture and work shop : 08.03.07 Leonardo City Tower London Hall the lecture will be given by: David J Brooks MD DSc FRCP. Hartnett Professor for Neurology Hammersmith Hospital, London. For more in formation and registration please contact us at 03-9130314 or at the following… Read More

Lu177 PSMA- Isotopia starts producing Lu177 PSMA for advanced prostate cancer treatment!

February 2016- Isotopia starts producing Lu177 PSMA for advanced prostate cancer treatment and working with collaboration with RAMBAM medical center, the first to use this treatment. Lutetium-177 PSMA Therapy, or Prostate-Specific Membrane Antigen Therapy, is treatment that is increasingly being used for people with advanced prostate cancer. Lu177 PSMA  therapy aims to reduce the size… Read More

Isotopia is joining Janssen to promote knowledge and collaboration in the field of prostate cancer.

Isotopia is joining Janssento promote knowledge and collaboration in the field of prostate cancer. Bringing together physicians from urology, oncology and nuclear medicine. As a leader in the imaging field, presenting Ga68 PSMA, Isotopia is joining JANSSEN, a leader in treatment.   For the SAVE THE DATE brochure - 7-8.04.16 Read More
nuclear

The annual conference of the Israeli Association of Nuclear Medicine SAVE THE DATE!

3-5  March 2016, Canaan Spa Hotel, Mount Canaan, ZEFAT. You are invited to take part in the annual conference of the Israeli Association of Nuclear Medicine, which will take place on Thursday, Saturday - 3-5.03.2016,  Canaan Spa Hotel.   Nuclear Medicine Association Conference is the main meeting. This platform Creates good opportunities to interact in a… Read More

Isotopia supporting the new movement disorder clinic opening at the BARZILAI Hospital.

Isotopia supporting the new movement disorder clinic opening at the BARZILAI Hospital. As a leader in the imaging field, presenting F18 DOPA, for the imaging of Parkinson's disease.   For SAVE THE DATE invitation - 21.01.16   Read More
Des 2015

Des 2015 – Isotopia is collaborating with D”r Zohar Dotan head of the Uro-oncologists forum

Isotopia is collaborating with D"r Zohar Dotan head of the Uro-oncologists forum to promote knowledge in the field of imaging and therapy of prostate cancer. Bringing together physicians from urology, oncology and nuclear medicin. As a leader in the imaging field, presenting Ga68 PSMA, Also bringing a world leading Physician from Heidelberg Germany to speak about… Read More
Presentation4-320x226

Sponsoring neurological conference F18 DOPA lecture

As part of a coloration with the Israeli Neurological organization, Isotopia is supporting update congress that will take place on the 10th of June 2015. Dr. Hassin, Manager of the Shiba hospital movement disorder department, will present [ 18F] fluoroDOPA PET Scan that is manufactured in Isotopia. This will be the third time Isotopia is taking part in establishing awareness… Read More
4265545-6_frenchweb2

Isotopia supporting the BRAINSTORMING PD 7 (2015)

As part of a coloration with the Israeli PD organization, Isotopia is supporting the 7th BRAINSTORMING congress From Symptoms through Better Understanding to Treatment and Prevention. Isotopia will present [ 18F] fluoroDOPA PET Scan. For more information on PD organization: http://www.parkinson.org.il/   BSPD 7 (2015) final program     Read More
Capsule-in-Hand-320x300

Isotopia collaborates with Check-Cap Ltd.

Isotopia is producing a capsulated device for clinical trail!. Check-Cap Ltd. (Check-Cap) is a clinical stage medical diagnostics company, founded in 2005, that believes it has developed a unique solution for colorectal cancer (CRC) screening. The technology is packed into a capsulated device that is designed to detect clinically significant polyps with high sensitivity. Our technology does… Read More
GA68-PSMA-web

December 2014- G68- PSMA is launched for the diagnosis of prostate cancer

PSMA Prostate Cancer For the first time in Israel, 68Ga-labelled PSMA ligand, is now available to the market on a regular basis.  Positron emission tomography (PET) with 68Ga-labelled PSMA ligand  for the diagnosis of prostate cancer (PC). prostate-specific membrane antigen (PSMA) is overexpressed in most PCs, Therefore, a 68Ga-labelled PSMA ligand is superior to choline tracers by obtaining a high contrast. NIOSH… Read More
4265545-6_frenchweb2

June 2014- F- DOPA is launched

6-[18F] Fluoro-L-3,4-dihydroxyphenylalanine also known as Fluorodopa F18 and F-DOPA is now available to the market on a regular basis. Fluorodopa F 18 ( 18F-dopa)is used with positron emission tomography (PET) to visualize the regional distribution of the neurotransmitter dopamine in the human brain18F-dopa with PET is used to assess presynaptic dopaminergic function in vivo in… Read More

April 2014- Y90 ZEVALIN Marketing Authorization in Israel

In an agreement with Spectrum Pharmaceuticals (www.sppirx.com), Isotopia is in the advanced stages of receiving the marketing authorization (MA) for the radioimmunotherapeutic agent ZEVALIN (ibritumomab tiuxetan, IDEC-Y2B8) in Israel. As part of this arrangement the YTRACIS Yttrium 90 Radiopharmaceutical precursor solution marketing authorization from IBA Molecular (CISbio) for Israel will also be held by Isotopia. Read More

Feb 2014- Isotopia & IBA Molecular CISbIO are participating in the Israel Society of Nuclear Medical annual meeting.

We are presenting to the community advances and developments in Nuclear Medicine and Molecular Imaging with a focus on Tc-99m-labeled SCINTIMUN (Besilesomab). A key note lecture by Prof.Denis Agostini MD , Professor of Nuclear Medicine and Biophysics, University of Caen , France will be on "How to manage prosthetic joint infection using Tc-99m-labeled antigranulocyte (Besilesomab)… Read More

Jan 2014- Isotopia attains ISO9001 accreditation

To further strengthen Isotopia's strict quality assurance practices, Isotopia is audited and found to comply with the Quality Management Standard ISO9001 Read More

Jan 2014- Isotopia attains ISO9001 accreditation

To further strengthen Isotopia's strict quality assurance practices, Isotopia is audited and found to comply with the Quality Management Standard ISO9001. Read More

Dec 2013- Y90 labeled Zevalin for clinical trial

In an agreement with SPECTRUM Pharmaceuticals (http://www.sppirx.com) , Isotopia is providing labeled Y90 ZEVALIN for multiple centers in Israel involved in a clinical trial -ZEST. The trial is looking at a type of non Hodgkin lymphoma called diffuse large B cell lymphoma. Click here for more info. Read More

November 2013- F-choline is now produced in Israel, another first from Isotopia

Isotopia launches F18- choline (FCH) and makes it available on a regular basis. FCH is used for imaging of primary and recurrent prostate cancer. Read More
Loading...

Email news feed

Insert the following characters: captcha